Average Co-Inventor Count = 4.37
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Array Biopharma Inc. (15 from 329 patents)
15 patents:
1. 8513293 - Methods of treating a hyperproliferative disorder or inhibiting cell growth in a mammal
2. 8193231 - Compositions comprising N3 alkylated benzimidazole derivatives as MEK inhibitors and methods of use thereof
3. 8193230 - Compositions comprising N3 alkylated benzimidazole derivatives as MEK inhibitors and methods of use thereof
4. 8193229 - Method of treatment using N3 alkylated benzimidazole derivatives as MEK inhibitors
5. 8178693 - N3 alkylated benzimidazole derivatives as MEK inhibitors
6. 8003805 - N3 alkylated benzimidazole derivatives as MEK inhibitors
7. 7973170 - N3 alkylated benzimidazole derivatives as MEK inhibitors
8. 7842816 - N3 alkylated benzimidazole derivatives as MEK inhibitors
9. 7777050 - N3 alkylated benzimidazole derivatives as MEK inhibitors
10. 7576072 - Heterocyclic inhibitors of MEK and methods of use thereof
11. 7576114 - N3 alkylated benzimidazole derivatives as MEK inhibitors
12. 7538120 - Method of treating inflammatory diseases
13. 7511058 - Heterocyclic inhibitors of MEK and methods of use thereof
14. 7425637 - N3 alkylated benzimidazole derivatives as MEK inhibitors
15. 7235537 - N3 alkylated benzimidazole derivatives as MEK inhibitors